share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga Real-time News ·  Dec 12, 2022 08:09

Gainers

  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock moved upwards by 170.4% to $1.46 during Monday's pre-market session. The market value of their outstanding shares is at $16.1 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares rose 88.58% to $6.55. The market value of their outstanding shares is at $33.3 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) stock increased by 36.72% to $0.51. The market value of their outstanding shares is at $29.2 million.
  • Harpoon Therapeutics (NASDAQ:HARP) shares moved upwards by 27.82% to $1.47. The market value of their outstanding shares is at $48.8 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock rose 22.52% to $3.1. The market value of their outstanding shares is at $39.8 million.
  • Biocept (NASDAQ:BIOC) shares moved upwards by 21.58% to $0.76. The market value of their outstanding shares is at $13.0 million.

Losers

  • Adicet Bio (NASDAQ:ACET) stock declined by 36.0% to $11.05 during Monday's pre-market session. The market value of their outstanding shares is at $473.5 million.
  • Ambrx Biopharma (NYSE:AMAM) stock declined by 25.56% to $3.38. The market value of their outstanding shares is at $130.5 million.
  • INVO Bioscience (NASDAQ:INVO) shares declined by 22.84% to $0.46. The market value of their outstanding shares is at $5.6 million.
  • Inotiv (NASDAQ:NOTV) stock declined by 22.19% to $4.42. The company's market cap stands at $113.1 million. As per the news, the Q4 earnings report came out today.
  • Baudax Bio (NASDAQ:BXRX) stock declined by 17.12% to $4.31. The market value of their outstanding shares is at $2.3 million.
  • Societal CDMO (NASDAQ:SCTL) stock declined by 14.97% to $1.08. The company's market cap stands at $61.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment